NanoLuxe: a market analysis, pricing policy and regulatory affairs for an anti-counterfeit company based on nanotechnology

Abstract

Counterfeit is an ever-present phenomenon that involves making illegal copies of valuable items with the intention of making profit from their transactions. The vulnerabilities in the supply chain of medical devices have set the ground for these criminal groups to target the medical industry. Substandard and unauthorized medical products are currently in the market, putting millions of people at risk and being a serious threat to public health. NanoLuxe is a company that is developing a system to label and identify products with barcoded-nanoparticles, guaranteeing the traceability and authentication of goods down the supply chain. A market analysis is performed in order to evaluate whether this business could be profitable in the medical devices industry. With the information gathered in the market analysis and the definition of a clear market niche, a pricing policy and strategy is carried out. Accordingly, this is accomplished by analyzing the level of competition, the supply and demand curves, the scalability of the sector and the cost-effectiveness of the technology. Furthermore, the regulatory affairs that this technology requires at an European level and under the FDA (Foods & Drugs Administration) regulations are assessed.